Resolution of gouty tophi after twelve weeks of pegloticase treatment

被引：30

作者：

Baraf, Herbert S. B. ^{[1
]}

Matsumoto, Alan K. ^{[1
]}

Maroli, Allan N. ^{[2
]}

Waltrip, Royce W., II ^{[2
]}

机构：

[1] Ctr Rheumatol & Bone Res, Wheaton, MD USA

[2] Savient Pharmaceut Inc, E Brunswick, NJ USA

来源：

ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 11期

关键词：

D O I：

10.1002/art.23993

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：3632 / 3634

页数：3

共 14 条

[1] Serum uric acid-lowering therapies: where are we heading in management of hyperuricemia and the potential role of uricase. [J].

Bomalaski J.S. ;

Clark M.A. .

Current Rheumatology Reports, 2004, 6 (3) :240-247

[2] Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of Hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma:: Results of the GRAAL1 [J].

Coiffier, B ;

Mounier, N ;

Bologna, S ;

Fermé, C ;

Tilly, H ;

Sonet, A ;

Christian, B ;

Casasnovas, O ;

Jourdan, E ;

Belhadj, K ;

Herbrecht, R .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (23) :4402-4406

[3] PURIFICATION OF URICASE FROM MAMMALIAN TISSUE [J].

CONLEY, TG ;

PRIEST, DG .

PREPARATIVE BIOCHEMISTRY, 1979, 9 (02) :197-203

[4] Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase [J].

Ganson, NJ ;

Kelly, SJ ;

Scarlett, E ;

Sundy, JS ;

Hershfield, MS .

ARTHRITIS RESEARCH & THERAPY, 2006, 8 (01)

[5]

Li-Yu J, 2001, J RHEUMATOL, V28, P577

[6] Rasburicase treatment in severe tophaceous gout: a novel therapeutic option [J].

Moolenburgh, J. D. ;

Reinders, M. K. ;

Jansen, T. L. Th. A. .

CLINICAL RHEUMATOLOGY, 2006, 25 (05) :749-752

[7] Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout [J].

Perez-Ruiz, F ;

Calabozo, M ;

Pijoan, J ;

Herrero-Beites, AM ;

Ruibal, A .

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2002, 47 (04) :356-360

[8]

Richette P, 2007, J RHEUMATOL, V34, P2093

[9]

ROZENBERG S, 1995, REV RHUM, V62, P413

[10] Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout (vol 56, pg 1021, 2007) [J].

Sundy .

ARTHRITIS AND RHEUMATISM, 2007, 56 (04) :1370-1370

← 1 2 →